Next Thur Oct 10 I will start either a phase 1 trial or take regorafenib. Basically, if the screen process indicates I am eligible for the trial, I most likely will start the trial. Currently I am communicating with the trial's principal investigator in order to have a few questions of mine on the trial drug's toxicity answered, though.
Because I took Keytruda during Mar-May of this year, I am excluded from most Phase II or I/O trials. The remaining drugs besides Regorafenib are TAS-102 and possibly reuse of Cetuximab.
Then wait for magic.